Acceptance Factors and Psychological Investigation of Clinical Trials in Cancer Patients
Aim. To understand the degree of oncology patients’ awareness of drug clinical trials and oncology patients’ willingness to participate in drug clinical trials and the factors influencing them. Methods. The differences in the relevant variables of patients’ willingness to accept clinical trials were...
Gespeichert in:
Veröffentlicht in: | Behavioural neurology 2023-11, Vol.2023, p.1-8 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Aim. To understand the degree of oncology patients’ awareness of drug clinical trials and oncology patients’ willingness to participate in drug clinical trials and the factors influencing them. Methods. The differences in the relevant variables of patients’ willingness to accept clinical trials were analyzed, and a descriptive analysis was done for the measurement data (mean and standard deviation). Pearson’s correlation coefficient analysis was used to examine the correlation between willingness and the demographic variables. Stepwise regression analysis was used to explore the influencing factors of patients’ willingness to accept clinical trials. Results. There were no statistical differences in age, gender, education level, marital status, place of residence, monthly income, medical payment method, and treatment time (P>0.05). Patients’ willingness to accept drug clinical trials differed in their cognitive degree of clinical drug trials (P=0.002). Patients’ willingness to accept drug clinical trials differed in their experience in clinical trials (P |
---|---|
ISSN: | 0953-4180 1875-8584 |
DOI: | 10.1155/2023/5617575 |